LeMaitre Vascular to Acquire XenoSure Rights for $4.6mm

[at noodls] – – $4.5mm XenoSure LTM Revenues, +61% vs. Prior Year – BURLINGTON, Mass., Oct. 1, 2012 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, … more

View todays social media effects on LMAT

View the latest stocks trending across Twitter. Click to view dashboard